Related Experiment Video
Updated: Jul 12, 2025

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Coronary physiology thresholds associated with microvascular obstruction in myocardial infarction
Stefano Benenati1,2, Matteo Montorfano3, Silvia Pica4
1Cardiovascular Disease Chair, Department of Internal Medicine (Di.M.I.), University of Genova, Genova, Liguria, Italy.
Insights
Invasive assessment of coronary flow reserve (CFR) and index of microvascular resistance (IMR) can identify microvascular obstruction after ST-elevation myocardial infarction (STEMI). Patients with high IMR and low CFR show worse outcomes, including larger infarct size.
Area of Science:
- Cardiology
- Cardiovascular Research
- Interventional Cardiology
Background:
- ST-segment elevation myocardial infarction (STEMI) requires prompt treatment to restore blood flow.
- Microvascular obstruction can occur despite successful reperfusion, impacting patient outcomes.
- Assessing coronary physiology post-intervention is crucial for risk stratification.
Purpose of the Study:
- To evaluate the association between invasive coronary physiology assessment and microvascular obstruction in STEMI patients.
- To determine optimal cut-off values for index of microvascular resistance (IMR) and coronary flow reserve (CFR) in predicting microvascular obstruction.
- To compare novel stratification models with existing ones.
Main Methods:
- Prospective enrollment of 102 STEMI patients across five Italian tertiary centers (November 2020 - December 2021).
- Measurement of CFR and IMR in the culprit vessel immediately after primary percutaneous coronary intervention.
- Stratification of patients into four groups based on optimal IMR and CFR cut-off points.
Main Results:
- Optimal cut-off points identified as IMR > 31 units and CFR ≤ 1.25.
- Patients with IMR > 31 and CFR ≤ 1.25 had significantly higher microvascular obstruction (83% vs 38%, p<0.001) and lower ejection fraction (45±9% vs 52±9%, p=0.043).
- This high-risk group also exhibited larger infarct size and area at risk compared to other groups.
Conclusions:
- IMR and CFR are reliable indicators of microvascular obstruction in STEMI.
- An IMR > 31 units and CFR ≤ 1.25 identifies STEMI patients at high risk for adverse outcomes.
- These physiological parameters aid in risk stratification and management decisions post-PCI.
Objectives:
To ascertain whether invasive assessment of coronary physiology soon after recanalisation of the culprit artery by primary percutaneous coronary intervention is associated with the development of microvascular obstruction by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction (STEMI).
Methods:
Between November 2020 and December 2021, 102 consecutive patients were prospectively enrolled in five tertiary centres in Italy. Coronary flow reserve (CFR) and index of microvascular resistance (IMR) were measured in the culprit vessel soon after successful primary percutaneous coronary intervention. Optimal cut-off points of IMR and CFR to predict the presence of microvascular obstruction were estimated, stratifying the population accordingly in four groups. A comparison with previously proposed stratification models was carried out.
Results:
IMR>31 units and CFR≤1.25 yielded the best accuracy. Patients with IMR>31 and CFR≤1.25 exhibited higher microvascular obstruction prevalence (83% vs 38%, p<0.001) and lower left ventricular ejection fraction (45±9% vs 52±9%, p=0.043) compared with those with IMR≤31 and CFR>1.25, and lower left ventricular ejection fraction compared with patients with CFR≤1.25 and IMR≤31 (45±9% vs 54±7%, p=0.025). Infarct size and area at risk were larger in the former, compared with other groups.
Conclusions:
IMR and CFR are associated with the presence of microvascular obstruction in STEMI. Patients with an IMR>31 units and a CFR≤1.25 have higher prevalence of microvascular obstruction, lower left ventricular ejection fraction, larger infarct size and area at risk.
Trial Registration Number:
NCT04677257.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Pathophysiology of Cardiac Performance

